| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |